Knights of Columbus Asset Advisors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-33,234
Closed -$757K 399
2024
Q2
$757K Sell
33,234
-30,011
-47% -$693K 0.05% 276
2024
Q1
$1.92M Sell
63,245
-60,295
-49% -$2.02M 0.14% 201
2023
Q4
$4.41M Buy
123,540
+77,055
+166% +$2.87M 0.28% 147
2023
Q3
$2.04M Buy
+46,485
New +$2.27M 0.19% 172
2021
Q1
Sell
-46,263
Closed -$2.58M 323
2020
Q4
$2.58M Buy
46,263
+6,053
+15% +$262K 0.27% 128
2020
Q3
$1.6M Buy
+40,210
New +$1.71M 0.2% 168

Other funds holding ATRC

Knights of Columbus Asset Advisors's ATRC Position: Q3 2024 in Review

Knights of Columbus Asset Advisors sold out of AtriCure (ATRC) in Q3 2024, closing a stake of 33,234 shares — an estimated $757K sold.

Knights of Columbus Asset Advisors first reported a position in ATRC in Q3 2020 and held it in 6 quarters. The position peaked at $4.41M in Q4 2023. 201 funds tracked by Wall St. Rank hold ATRC as of Q3 2024.

  • Knights of Columbus Asset Advisors reported no remaining AtriCure position as of Q3 2024 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 33,234 AtriCure shares in Q3 2024, an estimated $757K.
  • Knights of Columbus Asset Advisors first reported a position in AtriCure in Q3 2020 and held it in 6 quarters.
  • Knights of Columbus Asset Advisors's AtriCure position peaked at $4.41M in Q4 2023.
  • 201 funds tracked by Wall St. Rank held AtriCure as of Q3 2024.

Based on Knights of Columbus Asset Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.